Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience

Tyrosine kinase inhibitors (TKI) have shown clinical effectiveness in iodine-refractory differentiated thyroid cancer (DTC). The corresponding role of serum thyroglobulin (Tg) in iodine-refractory DTC has not been investigated yet. 9 patients (3 female, 61 ± 8y) with progressive iodine-refractory DT...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, R. A., Lückerath, K., Schmid, J. S., Higuchi, T., Kreissl, M. C., Grelle, I., Reiners, C., Buck, A. K., Lapa, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910099/
https://www.ncbi.nlm.nih.gov/pubmed/27306607
http://dx.doi.org/10.1038/srep28081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910099/
https://www.ncbi.nlm.nih.gov/pubmed/27306607
http://dx.doi.org/10.1038/srep28081

Ejemplares similares